PLTR vs TSHA · P/E 584, rev $3.57B vs $640.7M cap
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the PLTR and TSHA stock pages for the full models.
Not investment advice.